Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GTBP

GT Biopharma, Inc.

CIK 0000109657 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.29
↑ 0.01 (2.34%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$10.41M
P/E Ratio
Not covered
EPS
-6.68
Dividend Yield
Not covered
52W Position
2%
Beta
1.94

Valuation multiples

Fwd P/E
17.33
PEG
1.05
P/B
2.92
P/S
Not covered
EV/Revenue
Not covered
ROE
Not covered
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 2%
$0.26$1.37

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$28.35M
Total Assets
$8.11M
Free Cash Flow
–

Recent news